Future studies should validate these findings and evaluate the predictive value of K17 IHC testing in retrospective analyses using cohorts of PDAC cases involved in precision medicine testing, potentially including the Pancreatic Cancer Action Network “Know Your Tumor” initiative38, among others. Here, KRT17 is linked to familial pancreatic carcinoma.